 |
Tazemetostat |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-28 00:00:00 |
| Sponsor | Epizyme Inc.;400 Technology Square, 4th Floor;Cambridge, Massachusetts, 02139 |
| |
Tazemetostat |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-28 00:00:00 |
| Sponsor | Epizyme Inc.;400 Technology Square, 4th Floor;Cambridge, Massachusetts, 02139 |